| [1] |
YAO Si-fan, ZHANG Xin, SHEN Li-xia.Effects of Tau Protein on Mitochondrial Function in Alzheimer's Disease[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(4): 54-. |
| [2] |
WANG Tian-xu, LIU Ci, CUI Yong-yuan, ZHANG Xin, WU Miao-miao, SHEN Li-xia.Explore the Mechanism of Quercetin in the Treatment of Alzheimer's Disease by Network Pharmacology and Molecular Docking[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(2): 31-. |
| [3] |
.Exploring the Effect and Mechanism of Pterostilbene on Alzheimer’s Disease Based on Network Pharmacology[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(5): 1-. |
| [4] |
GUO Bao, ZHANG Qiao-qiao, JING Yong-shuai, ZHANG Dan-shen.Protective Effect of Joseonol on the Mediation of Neurological Diseases[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(3): 54-. |
| [5] |
YOU Si-han, YIN Hong-yan, LI Ze, XIA Lei, GUO Chun-yan.Prediction of the Target of Quercetin in the Treatment of Breast Cancer Based on Network Pharmacology[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(2): 6-. |
| [6] |
SI Wen-ying, HOU Yu-qing, SUN Xiao-jing, MENG Xian-yong, DONG Xiao-hua.Gene Therapy for Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(6): 51-56. |
| [7] |
ZHANG Zhi-qing, ZHANG Yong-cai, LIU Lin-xuan, LI Ren-qing, LIU Ji-jia, DU Jing-kao, JIANG Bei, WEI Huiping, SU Li-ning.Bioinformatics Analysis of the Relationship between Exosomal ceRNA Regulatory Network and Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(4): 23-40. |
| [8] |
CAI Yu-shan, ZHAO Shuai.Role of PPARβ/δ in Neurodegenerative Diseases[J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(4): 41-48. |
| [9] |
LV Xue-ying, ZHANG Zheng, LUO Huan-min.The Blood-Brain Barrier and Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(4): 58-64. |
| [10] |
DAI Yue-ying, ZHAO Yu-wei, YAO Si-fan, SHEN Li-xia.Neuroprotective Effect of Estrogen-Mediated Mitochondrial Pathway[J]. ACTA NEUROPHARMACOLOGICA, 2021, 11(3): 33-42. |
| [11] |
HUANG Ying, HUO Yan-li, MING Yue, HAO Jun-rong.Research Progress of High-Fat Diet and Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(6): 54-59. |
| [12] |
DING Sheng-kai, LIU Qing-qing, LIU Xin-yang, SHANG Ya-zhen.Relationship between Adult Hippocampus Neurogenesis and Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(6): 48-53. |
| [13] |
ZHANG Jia-xiu, ZOU Yu-an. Research Progress of SIRT1 in Cerebral Ischemia-Reperfusion Injury[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(6): 41-44. |
| [14] |
WANG Si-yi, LI Xian-xiang, LIU Yi-zhou, DU Shuang, GE Chao, LIU Si-si.Current Situation and Prospect of Alzeimer’s Disease Treatment[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 38-42. |
| [15] |
SUN Li-cong, ZHANG Dan-shen.Research Progress on Potential Treatment of Alzheimer’s Disease with Alkaloids[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 33-37. |